Erschienen in:
05.02.2023 | Original Article
Single centre analysis of perioperative complications in trans-oral robotic surgery for oropharyngeal carcinomas
verfasst von:
Angelo Cannavicci, Eleonora Cioccoloni, Francesco Moretti, Giovanni Cammaroto, Giannicola Iannella, Andrea De Vito, Rossella Sgarzani, Manlio Gessaroli, Andrea Ciorba, Chiara Bianchini, Virginia Corazzi, Pasquale Capaccio, Claudio Vicini, Giuseppe Meccariello
Erschienen in:
Indian Journal of Otolaryngology and Head & Neck Surgery
|
Ausgabe 2/2023
Einloggen, um Zugang zu erhalten
Abstract
Trans Oral Robotic Surgery (TORS) is a modality in the management of oropharyngeal squamous cell carcinoma(OPSCC). This study was conducted to show the rates of peri-operative complications after TORS for OPSCC in our experience. Single centre retrospective analysis of consecutive OPSCC treated with TORS. The surgical complication severity was recorded according to Clavien-Dindo criteria (CDC). Eighty-seven OPSCC were operated with TORS. According to CDC, grade I, grade II and IIIb were registered in 8%, 4.6% and 11.5% of cases, respectively. The postoperative pain, registered with visual-analogue scale (VAS) score, was 8 ± 1.2 for the secondary healing wounds and 6.2 ± 1.5 for the flap reconstructions (p < 0.01). The impact on swallowing function was not significant between secondary healing and flap reconstructions(p = 0.96). Any major or life-threatening intraoperative complications have not been recorded. Only one patient had postoperative bleeding into the neck whilst 13.3% of patients had postoperative bleeding from the primary tumor. No total local or free flap failure were registered. The mean duration of tracheostomy use was 7.4 ± 2.6 days, and nasogastric tube 14.3 ± 6.9 days. Only one patient, who had also reconstruction with flap, experienced a postoperative severe dysphagia with severe aspiration, needing a permanent tracheostomy tube and percutaneous endoscopic gastrostomy feeding. TORS for OPSCC showed less morbidity, lower risk of severe complication and mortality. Thus, this treatment modality could be offered as first line treatment in selected cases.